3.0.0 1958 2023-01-11T13:23:19Z 2023-01-11T13:23:19Z House H HR 2013-05-14 113 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CUMMINGS:H.R. 1958.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3 (relating to the power ofCongress to regulate Commerce with foreign Nations, and amongthe several States, and with the Indian Tribes.)[Page H2603]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2013-05-17T15:35:19Z Referred to 2013-05-14T16:00:34Z 2013-05-17 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2013-05-14 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2013-05-14 Introduced in House IntroReferral Intro-H 9 Library of Congress 2013-05-14 Introduced in House IntroReferral 1000 9 Library of Congress C000984 Rep. Cummings, Elijah E. [D-MD-7] ELIJAH CUMMINGS D MD E. 7 N Health Administrative law and regulatory procedures Business records Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Government information and archives Prescription drugs Retail and wholesale trades User charges and fees Health

00 2013-05-14 Introduced in House 2013-08-19T16:34:06Z Gray Market Drug Reform and Transparency Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to: (1) make it a prohibited act and a misbranding for a wholesale distributor of prescription drugs to purchase or receive a prescription drug from a pharmacy or a pharmacist, (2) require annual reporting by wholesale distributors of prescription drugs, (3) require the Secretary of Health and Human Services (HHS) to establish and maintain a national database of information reported by wholesale distributors of prescription drugs and to require such database to include information on actions taken by states against wholesale distributors (e.g., disciplinary actions and license revocations), (4) require the Secretary to assess and collect fees from wholesale distributors of prescription drugs, and (5) require wholesale distributors of prescription drugs to provide to recipients of a prescription drug in shortage the sales price for such drug at the time of its sale and at the time of any prior sale of such drug when it was in shortage.

]]>

Display Title Official Title as Introduced Introduced in House IH Short Titles as Introduced Introduced in House 2013-05-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr1958ih/xml/BILLS-113hr1958ih.xml 2013-05-17 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.